Navigation Links
Henry Schein to Present at the Deutsche Bank Small and Mid Cap Conference
Date:2/5/2010

MELVILLE, N.Y., Feb. 5 /PRNewswire-FirstCall/ -- Henry Schein, Inc., (Nasdaq: HSIC), the largest provider of health care products and services to office-based practitioners, announced today that Ferdinand Jahnel, Vice President and Treasurer for Henry Schein, will present at the Deutsche Bank Small and Mid Cap Conference on Monday, February 8, 2010.  The Conference is being held at The Ritz-Carlton, in Naples, Florida.  

Henry Schein's presentation is scheduled to begin at 4 p.m. ET and can be heard via live webcast by visiting www.henryschein.com, clicking on "Investor Relations" and following the link for "Webcasts."   A replay will be available on the Web site following the presentation.

About Henry Schein

Henry Schein, a Fortune 500® company and a member of the NASDAQ 100® Index, is the largest provider of health care products and services to office-based practitioners.  Recognized for its excellent customer service and highly competitive prices, the Company's four business groups – Dental, Medical, International and Technology – serve approximately 590,000 customers worldwide, including dental practitioners and laboratories, physician practices and animal health clinics, as well as government and other institutions.  Henry Schein operates through a centralized and automated distribution network, which provides customers in more than 200 countries with a comprehensive selection of more than 90,000 national and Henry Schein private-brand products in stock, as well as more than 100,000 additional products available as special-order items.  Henry Schein also provides exclusive, innovative technology offerings for dental, medical and veterinary professionals, including value-added practice management software and electronic health record solutions.  

Headquartered in Melville, N.Y., Henry Schein employs more than 13,500 people and has operations or affiliates in 23 countries.  The Company's net sales reached a record $6.4 billion in 2008.  For more information, visit the Henry Schein Web site at www.henryschein.com.

SOURCE Henry Schein, Inc.

RELATED LINKS
http://www.henryschein.com

'/>"/>

SOURCE Henry Schein, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Henry Schein to Present at the UBS 20th Annual Global Healthcare Services Conference
2. Henry Schein To Present At The Jefferies 2010 Global Healthcare Services Conference
3. Henry Schein Elects Dr. Bradley T. Sheares to Board of Directors
4. Henry Schein Works With Supplier Partners to Earmark $1 Million in Health Care Supplies for Haiti Earthquake Relief
5. Henry Schein to Present at the NASDAQ OMX 23rd Investor Program
6. Innovative Dental Education Initiative From Henry Schein, ADA And ADEA To Be Featured At ADA Annual Session In Hawaii
7. Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference
8. Pulse Systems Announces New Sales Representation in the Western United States
9. CEL-SCI to Present at 12th Annual BIO CEO & Investor Conference
10. ADVENTRX Appoints Icahn Representative to Board of Directors
11. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ... LLC , and named its founder as Diplomat,s chief ... Tennessee , will operate under Diplomat subsidiary ... offerings for health care partners to include IT outsourcing, ... "In an interoperable world, technology delivers comprehensive insight ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., a ... design, and immune-engineering today announced the launch of ... development of personalized therapeutic cancer vaccines. EpiVax has ... exclusive access to enabling technologies to the new ... will lead EpiVax Oncology as Chief Executive Officer. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... “The Journey: From the Mountains to the Mission Field”: ... souls in the Philippines. “The Journey: From the Mountains to the Mission Field” is ... Bible. She has taught all ages and currently teaches a class of ladies at ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... Maryland (PRWEB) , ... October 12, 2017 , ... ... magnetic drug delivery system that we intend to develop to enable prevention of ... can lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
Breaking Medicine News(10 mins):